Loading…
CSTL
CASTLE BIOSCIENCES, INC.NasdaqResearch view
Healthcare · Services-Medical Laboratories · SEC EDGAR FY 2025-12-31
Price history
Interactive · live data via TradingView🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Income$-24.2M
Sales$344.2M
Book/sh$15.41
Cash/sh$3.82
Dividend TTM$0.00
Payout—
Employees—
IPO—
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$94.1M
2021
$137.0M
2022
$219.8M
2023
$332.1M
2024
$344.2M
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $94.1M | $137.0M | $219.8M | $332.1M | $344.2M |
| Gross Profit | — | — | — | — | — |
| Operating Income | $-40.1M | $-72.9M | $-68.0M | $8.7M | $-42.8M |
| Net Income | $-31.3M | $-67.1M | $-57.5M | $18.2M | $-24.2M |
| Diluted EPS | $-1.24 | $-2.58 | $-2.14 | $0.62 | $-0.83 |
| Operating Cash Flow | $-19.0M | $-41.7M | $-5.6M | $64.9M | $64.3M |
| Free Cash Flow | $-22.5M | $-47.3M | $-19.2M | $36.5M | $28.3M |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
Follow the news. Follow the move.
CSTL story timeline
Company updates and connected market context, with the dated price move attached.
1
Stories
0
Direct
COMMUNITY · $CSTL0 theses
POST YOUR TAKE →Related Stocks
Loading peers…
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.